Kairali Ayurvedic Group (KAG) aims to achieve consolidated revenues of Rs 150 crore by FY26, nearly doubling its current revenue by focusing on organic growth. This goal will be driven by expansion across its three divisions: Ayurveda centres, hospitality, and Ayurvedic products, alongside tapping into domestic and international markets. It will also cover ramp-up of FMCG and OTC business.

The Group’s hospitality division includes its flagship 68-acre Ayurvedic Healing Village in Kerala, with upcoming facilities in Goa and Bali. The Bali asset, opening in 2026, will be larger than Kerala's centre, featuring more keys to attract international guests. The Kairali Ayurvedic Centers (KAC) currently operates in 11 Indian states, with plans to add 20 centres, scaling to 35 by FY26 under a company owned, company operated (COCO) model.

Domestic expansions will include Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and North-Eastern states. In the Ayurvedic product segment, Kairali Ayurvedic Products (KAPPL) aims for over two-fold growth, targeting Rs 50 crore by FY25 from the current Rs 20 crore. It plans to introduce smaller SKUs for tier-III cities to enhance accessibility.

Its manufacturing efforts are supported by two factories in Kerala and Tamil Nadu, which produce over 400 Ayurvedic medicines and herbal cosmetics, while itswarehouse in Varanasi will cater to Eastern region boosting operational efficiency. KAG’s holistic approach combines heritage preservation with strategic expansion across wellness, hospitality, and FMCG sectors, positioning it as a leader in the Ayurvedic industry.